Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
View ORCID ProfileChristian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, Alex Pizzini, Thomas Sonnweber, Barbara Holzer, Wolfgang Mayer, Harald Schennach, Judith Loeffler-Ragg, Rosa Bellmann-Weiler, Boris Hartmann, Ivan Tancevski, Günter Weiss, Christoph J. Binder, Markus Anliker, Andrea Griesmacher, Gregor Hoermann
doi: https://doi.org/10.1101/2021.02.17.21251907
Christian Irsara
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Alexander E. Egger
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Wolfgang Prokop
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Manfred Nairz
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Lorin Loacker
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Sabina Sahanic
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Alex Pizzini
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Thomas Sonnweber
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Barbara Holzer
3Austrian Agency for Health and Food Safety (AGES), Department for Animal Health, Moedling, Austria
Wolfgang Mayer
4Central Institute for Blood Transfusion and Immunology (ZIB), University Hospital of Innsbruck, Innsbruck, Austria
Harald Schennach
4Central Institute for Blood Transfusion and Immunology (ZIB), University Hospital of Innsbruck, Innsbruck, Austria
Judith Loeffler-Ragg
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Rosa Bellmann-Weiler
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Boris Hartmann
3Austrian Agency for Health and Food Safety (AGES), Department for Animal Health, Moedling, Austria
Ivan Tancevski
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Günter Weiss
2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
Christoph J. Binder
5Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Markus Anliker
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Andrea Griesmacher
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
Gregor Hoermann
1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
6MLL Munich Leukemia Laboratory, Munich, Germany
Posted February 19, 2021.
Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, Alex Pizzini, Thomas Sonnweber, Barbara Holzer, Wolfgang Mayer, Harald Schennach, Judith Loeffler-Ragg, Rosa Bellmann-Weiler, Boris Hartmann, Ivan Tancevski, Günter Weiss, Christoph J. Binder, Markus Anliker, Andrea Griesmacher, Gregor Hoermann
medRxiv 2021.02.17.21251907; doi: https://doi.org/10.1101/2021.02.17.21251907
Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander E. Egger, Wolfgang Prokop, Manfred Nairz, Lorin Loacker, Sabina Sahanic, Alex Pizzini, Thomas Sonnweber, Barbara Holzer, Wolfgang Mayer, Harald Schennach, Judith Loeffler-Ragg, Rosa Bellmann-Weiler, Boris Hartmann, Ivan Tancevski, Günter Weiss, Christoph J. Binder, Markus Anliker, Andrea Griesmacher, Gregor Hoermann
medRxiv 2021.02.17.21251907; doi: https://doi.org/10.1101/2021.02.17.21251907
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)